Mayne Pharma to pay A$33M in class action settlement on alleged US conduct
Mayne Pharma (ASX:MYX) has announced it will pay A$38M – $4.7M covered by insurance – to settle a class action brought in 2021.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No Corporate Spotlight currently available.